Warhound launches $200 million gene-edited dog venture

Warhound, a Texas startup founded by Anduril's Palmer Luckey and Colossal Biosciences' Ben Lamm, has raised $200 million. The company is gene-editing its first group of dogs for military, law enforcement and first responder use. It plans to clone selected high-performing dogs and is initially targeting inherited health problems such as hip dysplasia. Warhound says its first puppies could arrive in early 2027. Investors reportedly valued the startup at $1.2 billion. Warhound says the effort could strengthen the U.S. supply of working dogs and reduce reliance on European breeders while improving the animals' health and performance. The company may later explore changes intended to enhance abilities such as scent detection. It plans to provide equipment and software, including protective gear, rather than implanting computers in the dogs. Rated coverage does not show disputes over the funding, founders, or stated plans. What remains open is whether puppies arrive on the early 2027 timeline and how far any later performance-related changes go.